Xenova nets £19.4mm in private UK and US placements
Executive Summary
Oncology and immunology drug company Xenova Group PLC raised net proceeds of £19.4mm ($32.9mm) through the sale of 18.7mm units priced at £1.13 apiece (a 14% discount to the market average). Each unit consisted of 10 shares and 3 warrants, amounting to an aggregate of about 187mm shares and 56mm warrants.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Investment in Public Equity
- Private Placement
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice